Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Marco, Arndt"'
Autor:
Leonard A. Lobbes, Marcel A. Schütze, Raoul Droeser, Marco Arndt, Ioannis Pozios, Johannes C. Lauscher, Nina A. Hering, Benjamin Weixler
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 9, p 8198 (2023)
Muscarinic acetylcholine receptor M3 (M3R) has repeatedly been shown to be prominently expressed in human colorectal cancer (CRC), playing roles in proliferation and cell invasion. Its therapeutic targetability has been suggested in vitro and in anim
Externí odkaz:
https://doaj.org/article/2634da35d73d467f97caa6dd48c77442
Autor:
Ioannis Pozios, Nina A. Hering, Emily Guenzler, Marco Arndt, Sefer Elezkurtaj, Thomas Knösel, Christiane J. Bruns, Georgios A. Margonis, Katharina Beyer, Hendrik Seeliger
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 149:271-280
Purpose Interleukin 6 (IL-6), Oncostatin M (OSM), and downstream effector STAT3 are pro-tumorigenic agents in pancreatic ductal adenocarcinoma (PDAC). Glycoprotein 130 (gp130) is a compound of the IL-6 and OSM receptor complex that triggers STAT3 sig
Autor:
Marco Arndt, Mario H. Mueller, Elisabeth M. Hahn, Lisa Hartmann, Martin E. Kreis, Nina A. Hering
Publikováno v:
Surgery. 170:1442-1447
Background Postoperative ileus entails pathophysiological changes in mucosal permeability and an intestinal inflammatory immune response. We hypothesized that preoperative selective decontamination of the digestive tract combined with preoperative me
Autor:
Ioannis Pozios, Nina A. Hering, Emily Guenzler, Marco Arndt, Sefer Elezkurtaj, Thomas Knösel, Christiane J. Bruns, Georgios A. Margonis, Carsten Kamphues, Martin E. Kreis, Katharina Beyer, Hendrik Seeliger
Background: Interleukin-6 (IL-6), Oncostatin-M (OSM) and the major downstream effector STAT3 are pro-tumorigenic agents in many cancers, including pancreatic ductal adenocarcinoma (PDAC). Glycoprotein 130 (gp130) is a compound of the IL-6 and OSM rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::247f22b534271cabd2c9e3fa75431200
https://doi.org/10.21203/rs.3.rs-1602630/v1
https://doi.org/10.21203/rs.3.rs-1602630/v1
Autor:
Ani K. Stoyanova, Arne Sattler, Elisabeth M. Hahn, Nina A. Hering, Marco Arndt, Johannes Christian Lauscher, Fiona Speichinger-Hillenberg, Katja Kotsch, Ann-Kathrin Berg, Katharina Beyer
Publikováno v:
Cancers
Volume 15
Issue 5
Pages: 1475
Volume 15
Issue 5
Pages: 1475
The TNF-superfamily member TRAIL is known to mediate selective apoptosis in tumor cells suggesting this protein as a potential antitumor drug target. However, initial successful pr-clinical results could not be translated into the clinic. Reasons for
Publikováno v:
2022 Annual Reliability and Maintainability Symposium (RAMS).
Autor:
Nina A. Hering, Emily Günzler, Marco Arndt, Miriam Zibell, Johannes C. Lauscher, Martin E. Kreis, Katharina Beyer, Hendrik Seeliger, Ioannis Pozios
Publikováno v:
Cancers; Volume 15; Issue 2; Pages: 456
Interleukine-6 plays a key role in the progression and poor survival in pancreatic ductal adenocarcinoma (PDAC). The present study aimed to clarify if targeting the interleukin-6/glycoprotein-130 signaling cascade using the small-molecule gp130 inhib
Autor:
Ioannis Pozios, Georgios Antonios Margonis, Katharina Beyer, Marco Arndt, Nina A. Hering, E Günzler, Martin E. Kreis, Carsten Kamphues, Hendrik Seeliger
Publikováno v:
Viszeralmedizin 2021 Gemeinsame Jahrestagung Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), Sektion Endoskopie der DGVS, Deutsche Gesellschaft für Allgemein und Viszeralchirurgie (DGAV).
Autor:
Martin E. Kreis, Rayoung Kim, Nina A. Hering, Ioannis Pozios, Marco Arndt, Benjamin Weixler, Verena Liu, Katharina Beyer, Raoul A. Droeser, Hendrik Seeliger
Publikováno v:
Cancers, Vol 13, Iss 3220, p 3220 (2021)
Cancers
Volume 13
Issue 13
Cancers
Volume 13
Issue 13
Cholinergic signaling via the muscarinic M3 acetylcholine receptor (M3R) is involved in the development and progression of colorectal cancer (CRC). The present study aimed to analyze the blocking of M3R signaling in CRC using darifenacin, a selective
Publikováno v:
Proceedings of the 31st European Safety and Reliability Conference (ESREL 2021).